STEMCELL Technologies completes acquisition of substantially all assets of SQZ Biotechnologies
Acquiring Company
STEMCELL Technologies
Acquired Company
Sqz
Vancouver
MassachusettsBiotechnologyBiotechnologyDescription
STEMCELL Technologies has successfully acquired substantially all assets of SQZ Biotechnologies, marking a significant milestone for STEMCELL as it expands its portfolio and capabilities in the biotechnology sector. This acquisition paves the way for STEMCELL to further develop innovative cell therapies and strengthens its position in the global life sciences sector.
Quick answer
STEMCELL Technologies is acquiring Sqz, announced February 29, 2024. STEMCELL Technologies is based in Vancouver, British Columbia, Canada.
- How much did STEMCELL Technologies pay for Sqz?
- The deal value was not disclosed.
- What does STEMCELL Technologies do?
- STEMCELL Technologies is Canada’s largest biotechnology company, known for providing more than 2,500 specialized reagents, tools, and services to support life sciences research.
- Where are STEMCELL Technologies and Sqz based?
- STEMCELL Technologies is based in Vancouver, British Columbia, Canada. Sqz is based in Massachusetts, Massachusetts, United States.
- Who are the decision-makers at STEMCELL Technologies?
- Fundz holds 1 contact at STEMCELL Technologies. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Biotechnology and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- ARTMS Inc. completes acquisition of Telix Pharmaceuticals Limited to strengthen medical isotope production (April 12, 2024)
- Century Therapeutics strengthens position in autoimmune disease through $60 Million Private Placement and Acquisition of Clade Therapeutics, $60M (April 11, 2024)
- Ginkgo Bioworks completes acquisition of AgBiome's Platform Assets to expand biosecurity and ag biological discovery and development capabilities (April 11, 2024)
- Nuvation Bio Inc. completes acquisition of AnHeart Therapeutics Ltd. to enhance its oncology pipeline (April 10, 2024)
- Vertex Pharmaceuticals Incorporated to acquire Alpine Immune Sciences, Inc. for $4.9 billion in cash, $4.9B (April 10, 2024)
- CoreRx, Inc. completes acquisition of Societal CDMO, Inc. to enhance drug formulation and manufacturing capabilities (April 8, 2024)
Who to call at STEMCELL Technologies, and when
When STEMCELL Technologies changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day STEMCELL Technologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at STEMCELL Technologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at STEMCELL Technologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment STEMCELL Technologies makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Sqz?
Sqz was acquired by STEMCELL Technologies, based in Vancouver. The deal was reported on February 29, 2024. STEMCELL Technologies is Canada’s largest biotechnology company, known for providing more than 2,500 specialized reagents, tools, and services to support life sciences research. STEMCELL Technologies is privately held and operates in Biotechnology.
When did STEMCELL Technologies acquire Sqz?
STEMCELL Technologies's acquisition of Sqz was reported on February 29, 2024. STEMCELL Technologies has successfully acquired substantially all assets of SQZ Biotechnologies, marking a significant milestone for STEMCELL as it expands its portfolio and capabilities in the biotechnology sector. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Sqz do?
SQZ Biotechnologies Company, based in Massachusetts, is known for its innovative method of introducing therapeutic cargo into cells by squeezing them (mechanoporation). It is privately held, operating in Biotechnology, and is based in Massachusetts.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.